Testing times in an unhealthy sector
Asbestos-related deaths are mounting and with them, the volume of compensation having to be paid out to claimants and their dependents. Andrew Morgan asks whether insurers can cope with the continual drip, drip, drip of claims coming through.
Approximately 1500 people die from mesothelioma in the UK every year and about double that number are thought to die from asbestos-related lung cancer. These figures are set to rise until aboutOnly users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@postonline.co.uk
More on Claims
Is the home insurance market set for a reckoning?
Editor’s View: Emma Ann Hughes warns home insurers to brace themselves to be the next target of policyholders’ wrath as moaning motorists are replaced by angry-looking property owners on national newspapers’ personal finance pages.
Axa reveals how AI is transforming the business
Axa UK & Ireland has 12 “between proof of concept and proof of value” artificial intelligence initiatives currently ongoing across the business, according to CEO Tara Foley.
How insurance supports the growth of Glasgow
Analysis: Frances Stebbing investigates how insurance supports the growth of Glasgow and how the city is gaining ground against London for attracting and retaining fresh talent.
Could the FCA follow the Australian regulator’s claims lead?
After Australia’s financial regulator sent a letter to the country’s general insurance firms asking for improvement in claim handling practices, Vitesse’s CEO Philip Mcgriskin asks could the Financial Conduct Authority take a similar approach.
Diary of an Insurer: Charles Taylor’s Dr Lynn Gordon
Dr Lynn Gordon, chief medical officer at Charles Taylor Assistance, is a lifeline for a woman whose husband has died abroad and organises a patient’s long-haul repatriation from Australia to the UK.
Claims service is improving after some dark days
Data analysis: Claims service improved in the first quarter of 2024, although inconsistencies remain within the UK market, research conducted by Gracechurch has revealed.
Irish guidelines for assessing damages to push up premiums
Aine Tyrrell, partner at law firm DAC Beachcroft, explains why fresh guidelines for the assessment of damages in Northern Ireland could add to the costs faced by insurers and contribute further inflationary pressure to premiums for liability and motor products.
60 Seconds With... Value Space’s Reijo Pold
Reijo Pold, founder of Value Space, a technology company that uses satellites to conduct assessments for commercial properties and infrastructure, reveals he has been working since he was aged seven and doesn't even totally clock off when he goes on holiday.
Most read
- RSA ‘pragmatic’ on product review as NIG acquisition completes
- Direct Line Group confirms Milliner amid raft of leadership hires
- Wakam looking to exploit ‘unlimited UK potential’ following regulator approval